Kainos Laboratories, Inc. (4556) Stock Statistics & Valuation Metrics

Kainos Laboratories, Inc. has a market cap or net worth of ¥5.03B. The enterprise value is ―.

Kainos Laboratories, Inc. has 4,558,860 shares outstanding. The number of shares has decreased by -2.65% in one year.

Kainos Laboratories, Inc.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Kainos Laboratories, Inc. is ―. Kainos Laboratories, Inc.’s PEG ratio is ―.

In the last 12 months, Kainos Laboratories, Inc. had revenue of 5.06B and earned 637.97M in profits. Earnings per share was 152.26.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Kainos Laboratories, Inc. pays an annual dividend of ¥35, resulting in a dividend yield of 2.6%

Kainos Laboratories, Inc. upcoming earnings date is Jul 25, 2025, TBA (Confirmed).

Kainos Laboratories, Inc. as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Kainos Laboratories, Inc. has paid 292.10M in taxes.

Kainos Laboratories, Inc. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Kainos Laboratories, Inc. has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Kainos Laboratories, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―